El Paso ( EP) operates in the natural gas transmission and exploration and production sectors of the energy industry. Its purpose is to provide natural gas and related energy products in a safe, efficient and dependable manner. It was recently trading up $4.70, or 24%, at $24.29 after hitting a 52-week high of $24.61 earlier in the day. Today's Range: $23.40-$24.61 52-Week Range: $12.51-$24.61 Volume: 62 million Ratings: Of 10 analysts covering the stock, all 10 rate it a buy. TheStreet Ratings' has a C+ hold rating on El Paso. Kinder Morgan ( KMI) has agreed to buy El Paso for $21.1 billion in cash and stock. El Paso shows up in the portfolios of Leon Cooperman's Omega Advisors, with a new 4.2 million-share position initiated in the most recently reported quarter, and Daniel Loeb's Third Point, as the top holding with a 13 million-share position. Anadys Pharmaceuticals ( ANDS) is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C. It was recently trading up $2.61, or 251%, at $3.65 after hitting a 52-week high of $3.67 earlier in the day. Today's Range: $3.64-3.67 52-Week Range: 60 cents-$3.67 Volume: 39.2 million Ratings: Of 10 analysts covering the stock, seven rate it a buy, and three rate it a hold. Anadys has ageed to be acquired by Swiss drugmaker Roche Holding for $230 million. Anadys shows up on recent lists of 10 Hep C Stocks on Wall Street's Watch List and Stocks Under $5 Setting Up to Trade Higher.
El Paso Corporation (NYSE:EP) hit a new 52-week high Tuesday as it is currently trading at $30.50, above its previous 52-week high of $30.30 with 862,318 shares traded as of 9:50 a.m. ET. Average volume has been 10.6 million shares over the past 30 days.
El Paso Corporation (NYSE:EP) hit a new 52-week high Monday as it is currently trading at $29.44, above its previous 52-week high of $29.43 with 4.4 million shares traded as of 10:55 a.m. ET. Average volume has been 10.6 million shares over the past 30 days.